Multiple Evanescent White Dot Syndrome Following COVID-19 mRNA Vaccination

References

• Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–544. doi:10.1038/s41564-020-0695-z.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) [Internet]. COVID-19 vaccine tracker and landscape. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. Accessed November 14, 2021.
   Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Mulligan MJ, Lyke KE, Kitchin N, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults [published correction appears in nature. February 2021;590(7844):E26]. Nature. 2020;586(7830):589–593. doi:10.1038/s41586-020-2639-4.
   PubMed Web of Science ®Google Scholar
• Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020;383(25):2439–2450. doi:10.1056/NEJMoa2027906.
   PubMed Web of Science ®Google Scholar
• Shimabukuro T, Nair N. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine. JAMA. 2021;325(8):780–781. doi:10.1001/jama.2021.0600.
   PubMed Web of Science ®Google Scholar
• Maleki A, Look-Why S, Manhapra A, Foster CS. COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or coincidence? J Ophthalmic Vis Res. July 29, 2021;16(3):490–501. doi:10.18502/jovr.v16i3.9443.
   PubMed Web of Science ®Google Scholar
• Rehman O, Arya SK, Jha UP, Nayyar S, Goel I. Herpes Zoster ophthalmicus after COVID-19 vaccination: chance occurrence or more than that? [published online ahead of print, October 23, 2021]. Cornea. 2021. doi:10.1097/ICO.0000000000002881.
   Web of Science ®Google Scholar
• Jin W, Tang Y, Wen C. An ocular adverse event in temporal association with COVID-19 vaccination in a patient with systemic lupus erythematosus: a case report [published online ahead of print, October 7, 2021]. Hum Vaccin Immunother. 2021;1–3. doi:10.1080/21645515.2021.1976036.
   Web of Science ®Google Scholar
• Fowler N, Mendez Martinez NR, Pallares BV, Maldonado RS. Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. 2021;23:101136. doi:10.1016/j.ajoc.2021.101136.
   PubMedGoogle Scholar
• Koong LR, Chee WK, Toh ZH, Ng XL, Agrawal R, Ho SL. Vogt-Koyanagi-Harada disease associated with COVID-19 mRNA vaccine [published online ahead of print, September 10, 2021]. Ocul Immunol Inflamm. 2021;1–4. doi:10.1080/09273948.2021.1974492.
   Google Scholar
• Papasavvas I, de Courten C, Herbort CP Jr. Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination - report of three cases. J Ophthalmic Inflamm Infect. September 16, 2021;11(1):28. doi:10.1186/s12348-021-00260-4.
   PubMed Web of Science ®Google Scholar
• Valenzuela DA, Groth S, Taubenslag KJ, Gangaputra S. Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination. Am J Ophthalmol Case Rep. 2021;24:101200. doi:10.1016/j.ajoc.2021.101200.
   PubMedGoogle Scholar
• Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. Uveitis following the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association [published online ahead of print, August 2, 2021]. Retina. 2021;41:2462–2471. doi:10.1097/IAE.0000000000003277.
   PubMed Web of Science ®Google Scholar
• Smith E, Tran T, Gillies A, Yeung S, Ma PE. Multiple evanescent white dot syndrome following COVID-19 mRNA vaccination in two patients. Ocul Immunol Inflamm. February 24, 2022:1–4. doi:10.1080/09273948.2022.2032198. Epub ahead of print. PMID: 35201960.
   Web of Science ®Google Scholar
• Yasuda E, Matsumiya W, Maeda Y, et al. Multiple evanescent white dot syndrome following BNT162b2 mRNA COVID-19 vaccination. Am J Ophthalmol Case Rep. June 2022;26:101532. doi:10.1016/j.ajoc.2022.101532. Epub 2022 Apr 10. PMID: 35434421; PMCID: PMC8994682.
   PubMedGoogle Scholar
• Bolletta E, Iannetta D, Mastrofilippo V, et al. Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med. December 19, 2021;10(24):5960. doi:10.3390/jcm10245960. PMID: 34945256; PMCID: PMC8704915.
   PubMed Web of Science ®Google Scholar
• Inagawa S, Onda M, Miyase T, et al. Multiple evanescent white dot syndrome following vaccination for COVID-19: a case report. Medicine (Baltimore). January 14, 2022;101(2):e28582. doi:10.1097/MD.0000000000028582. PMID: 35029236; PMCID: PMC8758041.
   PubMed Web of Science ®Google Scholar
• Lin KS, Hsieh MH. Multiple evanescent white dot syndrome following medigen vaccine biologics corporation COVID-19 vaccination. Ocul Immunol Inflamm. April 20, 2022:1–4. doi:10.1080/09273948.2022.2062388. Epub ahead of print. PMID: 35442848.
   Web of Science ®Google Scholar
• Tomishige KS, Novais EA, Finamor LPDS, Nascimento HMD, Belfort R Jr. Multiple evanescent white dot syndrome (MEWDS) following inactivated COVID-19 vaccination (Sinovac-CoronaVac). Arq Bras Oftalmol. January 21, 2022;85(2):186–189. doi:10.5935/0004-2749.20220070. PMID: 35298582.
   PubMed Web of Science ®Google Scholar
• Xu Y, Shen W. Presumed recurrent MEWDS following Covid-19 vaccination. Ocul Immunol Inflamm. August 18, 2021;29(6):1234–1237. doi:10.1080/09273948.2021.1985524. Epub 2021 Oct 18. PMID: 34662254.
   PubMed Web of Science ®Google Scholar
• Jampol LM, Sieving PA, Pugh D, Fishman GA, Gilbert H. Multiple evanescent white dot syndrome. I. Clinical findings. Arch Ophthalmol. 1984;102(5):671–674. doi:10.1001/archopht.1984.01040030527008.
   PubMedGoogle Scholar
• Ng CC, Jumper JM, Cunningham ET Jr. Multiple evanescent white dot syndrome following influenza immunization - A multimodal imaging study. Am J Ophthalmol Case Rep. Published August 3, 2020;19:100845. doi:10.1016/j.ajoc.2020.100845.
   PubMedGoogle Scholar
• Pearlman RB, Golchet PR, Feldmann MG, et al. Increased prevalence of autoimmunity in patients with white spot syndromes and their family members. Arch Ophthalmol. 2009;127(7):869–874. doi:10.1001/archophthalmol.2009.132.
   PubMedGoogle Scholar
• Jampol LM, Becker KG. White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease. Am J Ophthalmol. 2003;135(3):376–379. doi:10.1016/s0002-9394(02)02088-3.
   PubMed Web of Science ®Google Scholar
• Papasavvas I, Mantovani A, Tugal-Tutkun I, Herbort CP Jr. Multiple evanescent white dot syndrome (MEWDS): update on practical appraisal, diagnosis and clinicopathology; a review and an alternative comprehensive perspective. J Ophthalmic Inflamm Infect. December 18, 2021;11(1):45. doi:10.1186/s12348-021-00279-7. PMID: 34921620; PMCID: PMC8684571.
   PubMed Web of Science ®Google Scholar
• Pereira F, Lima LH, de Azevedo AGB, Zett C, Farah ME, Belfort R Jr. Swept-source OCT in patients with multiple evanescent white dot syndrome. J Ophthalmic Inflamm Infect. October 13, 2018;8(1):16. doi:10.1186/s12348-018-0159-2. PMID: 30317398; PMCID: PMC6186261.
   PubMedGoogle Scholar
• Yang JS, Chen CL, Hu YZ, Zeng R. Multiple evanescent white dot syndrome following rabies vaccination: a case report. BMC Ophthalmol. Published December 7, 2018;18(1):312. doi:10.1186/s12886-018-0968-y.
   PubMedGoogle Scholar
• Abou-Samra A, Tarabishy AB. Multiple evanescent white dot syndrome following intradermal influenza vaccination. Ocul Immunol Inflamm. 2019;27(4):528–530. doi:10.1080/09273948.2017.1423334.
   PubMed Web of Science ®Google Scholar
• Ogino K, Kishi S, Yoshimura N. Multiple evanescent white dot syndrome after human papillomavirus vaccination. Case Rep Ophthalmol. Published February 1, 2014;5(1):38–43. doi:10.1159/000358870.
   PubMedGoogle Scholar
• Fine L, Fine A, Cunningham ET Jr. Multiple evanescent white dot syndrome following hepatitis a vaccination. Arch Ophthalmol. 2001;119(12):1856–1858. doi:10.1001/archopht.119.12.1870.
   PubMedGoogle Scholar
• Baglivo E, Safran AB, Borruat FX. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J Ophthalmol. 1996;122(3):431–432. doi:10.1016/s0002-9394(14)72074-4.
   PubMed Web of Science ®Google Scholar
• Cohen SM. Multiple evanescent white dot syndrome after vaccination for human papilloma virus and meningococcus. J Pediatr Ophthalmol Strabismus. 2009. doi:10.3928/01913913-20090616-01.
   PubMedGoogle Scholar
• Stangos A, Zaninetti M, Petropoulos I, Baglivo E, Pournaras C. Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination. Ocul Immunol Inflamm. 2006;14(5):301–304. doi:10.1080/09273940600932311.
   PubMed Web of Science ®Google Scholar
• Kostoff RN, Kanduc D, Porter AL, et al. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicol Rep. 2020;7:1448–1458. doi:10.1016/j.toxrep.2020.10.016.
   PubMed Web of Science ®Google Scholar
• Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses [published correction appears in nature. February 2021;590(7844):E17]. Nature. 2020;586(7830):594–599. doi:10.1038/s41586-020-2814-7.
   PubMed Web of Science ®Google Scholar
• Rodero MP, Crow YJ. Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med. 2016;213(12):2527–2538. doi:10.1084/jem.20161596.
   PubMed Web of Science ®Google Scholar
• Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, Mohammadi P, Nomovi M, Mowla A. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review. J Neurol Sci. 2021;428:117607. doi:10.1016/j.jns.2021.117607.
   PubMed Web of Science ®Google Scholar
• Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel). Published April 29, 2021;9(5):435. doi:10.3390/vaccines9050435.
   PubMed Web of Science ®Google Scholar
• Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021;21(4):195–197. doi:10.1038/s41577-021-00526-x.
   PubMed Web of Science ®Google Scholar
• Knoll MD, Wonodi C. Oxford-AstraZeneca COVID-19 vaccine efficacy. Lancet. 2021;397(10269):72–74. doi:10.1016/S0140-6736(20)32623-4.
   PubMed Web of Science ®Google Scholar
• Paltiel AD, Schwartz JL, Zheng A, Walensky RP. Clinical outcomes of a COVID-19 vaccine: implementation over efficacy. Health Aff (Millwood). 2021;40(1):42–52. doi:10.1377/hlthaff.2020.02054.
   PubMed Web of Science ®Google Scholar